| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Beta-blocker and ACE-inhibitor dosing as a function of body surface area: From the HF-ACTION trial
|
Brooksbank, Jeremy A.
|
|
|
233 |
C |
p. 1-4
|
artikel
|
| 2 |
Corrigendum to “Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry sub-analysis” [Am Heart J, 223 (2020), 23–33]
|
Akao, Masaharu
|
|
|
233 |
C |
p. 153
|
artikel
|
| 3 |
Differences between patients with cardiovascular disease and cancer referred for palliative care
|
Warraich, Haider J.
|
|
|
233 |
C |
p. 5-9
|
artikel
|
| 4 |
Divergent association of high levels of physical activity with cardiac versus noncardiac arterial calcification
|
Willis, Benjamin L.
|
|
|
233 |
C |
p. 10-13
|
artikel
|
| 5 |
Early intra-aortic balloon pump in acute decompensated heart failure complicated by cardiogenic shock: Rationale and design of the randomized Altshock-2 trial
|
Morici, Nuccia
|
|
|
233 |
C |
p. 39-47
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
233 |
C |
p. iii
|
artikel
|
| 7 |
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial
|
Sarraju, Ashish
|
|
|
233 |
C |
p. 141-148
|
artikel
|
| 8 |
Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
|
Salah, Husam M.
|
|
|
233 |
C |
p. 86-91
|
artikel
|
| 9 |
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale
|
Carnicelli, Anthony P
|
|
|
233 |
C |
p. 48-58
|
artikel
|
| 10 |
Information for Readers
|
|
|
|
233 |
C |
p. iv
|
artikel
|
| 11 |
iPhone App compared with standard blood pressure measurement –The iPARR trial
|
Dörr, Marcus
|
|
|
233 |
C |
p. 102-108
|
artikel
|
| 12 |
Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic
|
Vaishnav, Joban
|
|
|
233 |
C |
p. 122-131
|
artikel
|
| 13 |
Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort study
|
Rome, Benjamin N.
|
|
|
233 |
C |
p. 109-121
|
artikel
|
| 14 |
NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial
|
Fabris, Enrico
|
|
|
233 |
C |
p. 78-85
|
artikel
|
| 15 |
Paclitaxel-coated devices in the treatment of femoropopliteal stenosis among patients ≥65 years old: An ACC PVI Registry Analysis
|
Weissler, Elizabeth Hope
|
|
|
233 |
C |
p. 59-67
|
artikel
|
| 16 |
Response to: The paradox of implantable cardioverter-defibrillator: When guidelines play against care improvement
|
Chery, Godefroy S.
|
|
|
233 |
C |
p. 151-152
|
artikel
|
| 17 |
Risk markers of incident atrial fibrillation in patients with coronary heart disease
|
Tomasdottir MD, Maria
|
|
|
233 |
C |
p. 92-101
|
artikel
|
| 18 |
Sounding the alarm: Academic interventional cardiology at a crossroads
|
Klein, Lloyd W
|
|
|
233 |
C |
p. 14-19
|
artikel
|
| 19 |
Table of Contents
|
|
|
|
233 |
C |
p. i-ii
|
artikel
|
| 20 |
The associations between direct and delayed critical care unit admission with mortality and readmissions among patients with heart failure
|
Raslan, Ismail R.
|
|
|
233 |
C |
p. 20-38
|
artikel
|
| 21 |
The paradox of implantable cardioverter-defibrillator: When guidelines may play against care improvement
|
Disertori, Marcello
|
|
|
233 |
C |
p. 149-150
|
artikel
|
| 22 |
The role of cardiac testing with the 0/1-hour high-sensitivity cardiac troponin algorithm evaluating for acute myocardial infarction
|
McCord, James
|
|
|
233 |
C |
p. 68-77
|
artikel
|
| 23 |
Trends in health care resource use and expenditures in patients with newly diagnosed paroxysmal supraventricular tachycardia in the United States
|
Chew, Derek S.
|
|
|
233 |
C |
p. 132-140
|
artikel
|
Tijdschrift beschrijving